Andrew Huberman· PhD
If you go outside of the United States, everybody's talking about ApoB, it's in the guidelines in Europe and Canada, and everywhere else.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
If you go outside of the United States, everybody's talking about ApoB, it's in the guidelines in Europe and Canada, and everywhere else.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the Quebec Heart Study for you right there the cubic hard study has the stratification by all three of those metrics the Quebec hearts are you here I've kind of printed it up here yes it basically is showing it has nothing to do with the LDL see once you know the a poby look at the risk
canadians have long adopted the measurement of apob as the superior measurement to quantify ldl risk and yet here in the united states the guidelines still favor the use of ldl cholesterol which is clearly inferior to apob
but if you look at the canadian guidelines though they'll they'll tell you to measure it in everybody at least once in their in their lifetime
but if you look at the canadian guidelines though they'll they'll tell you to measure it in everybody at least once in their in
if you look at the canadian guidelines though they'll they'll tell you to measure it in everybody at least once in their in their lifetime